Study guide
10.3 Urinary Pathogens, Colony Counts, and Urinalysis Correlation
ASCP Microbiology Technologist M ASCP
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 Current M(ASCP) Exam Facts 1.2 CAT, Scoring, Retakes, and CMP 1.3 Eligibility Routes and Clinical Experience
2 Preanalytic: Collection and Transport
2.1 Patient Identification and Specimen Labeling 2.2 Specimen Collection, Sterile Technique, and Blood Cultures 2.3 Transport Devices, Atmosphere, Time, and Temperature
3 Preanalytic: Processing, Media, and Incubation
3.1 Prioritization, Rejection, and Specimen Preparation 3.2 Media Types, Components, and Selection 3.3 Inoculation, Incubation Conditions, and Slide Preparation
4 Preanalytic: Stains
4.1 Gram Stain: Procedure, Principle, and Interpretation 4.2 Acid-Fast and Modified Acid-Fast Stains 4.3 KOH, Calcofluor-White, Trichrome, Giemsa, and Acridine Orange
5 Bacteriology: Blood and Bone Marrow
5.1 Blood Culture Systems and Rapid Identification 5.2 Bloodstream Pathogens and Skin Flora Significance 5.3 Endocarditis, Bone Marrow Pathogens, and Pathogenicity
6 Bacteriology: CSF and Sterile Body Fluids
6.1 CSF Sources and Acute Meningitis Pathogens 6.2 Shunt Infections, CSF Correlates, Antigen and Molecular Methods 6.3 Sterile Body Fluids: Pathogens, Flora, and Molecular Methods
7 Bacteriology: Respiratory Tract
7.1 Lower Respiratory Specimens, CAP, and HAP Pathogens 7.2 Cystic Fibrosis Pathogens and Quantitative Reporting 7.3 Upper Respiratory: Pharyngitis, Otitis, Sinusitis, Antigen/Molecular
8 Bacteriology: Gastrointestinal Tract
8.1 Enteric Pathogens: Culture and Colony Morphology 8.2 Clostridioides difficile, Shiga Toxin, and Serotyping 8.3 Helicobacter pylori Detection and GI Pathogenicity
9 Bacteriology: Skin, Soft Tissue, and Bone
9.1 Skin, Soft Tissue, and Bone Pathogens 9.2 Bite Wounds and Zoonotic Infections 9.3 SST Pathogenicity and Virulence Mechanisms
10 Bacteriology: Genital Tract and Urine
10.1 Genital Flora and Vaginitis Pathogens 10.2 Neisseria gonorrhoeae, Chlamydia trachomatis, GBS, and Mycoplasma 10.3 Urinary Pathogens, Colony Counts, and Urinalysis Correlation
11 Bacteriology: Identification Methods
11.1 Colony Morphology and Rapid Presumptive Tests 11.2 Conventional Biochemicals and Commercial Kits 11.3 Automated Methods, MALDI-TOF MS, Molecular, and 16S Sequencing
12 Bacteriology: Antimicrobial Susceptibility and Resistance
12.1 Microbroth Dilution, Disk Diffusion, and Gradient Diffusion 12.2 Phenotypic Detection of Resistance 12.3 Antibiotic Classes, Intrinsic Resistance, and Genetic Markers
13 Bacteriology: Resistance Screening and Select Agents
13.1 MRSA/MSSA, VRE, ESBL/CRE Screening 13.2 BSL-3 Pathogens and Select-Agent Presumptive Identification 13.3 Laboratory Response Network and Select-Agent Pathogenicity
14 Mycobacteriology and Nocardia
14.1 Specimens, Major Pathogens, and Disease States 14.2 Acid-Fast Reaction, Colony Morphology, and Growth Characteristics 14.3 Identification Methods, Direct Molecular Detection, and TB Therapy
15 Virology
15.1 Respiratory, Vesicle, Meningitis, and GI Viruses 15.2 Hepatitis, HIV, and Immunocompromised-Host Viruses 15.3 Direct Detection Methods and HPV Cervical Screening
16 Parasitology
16.1 Blood, Tissue, and Brain Protozoa 16.2 Intestinal/Urogenital Protozoa and Helminths 16.3 Microscopy, Antigen/Molecular Detection, Insects and Arthropods
17 Mycology
17.1 Yeasts: Candida, Cryptococcus, and Malassezia 17.2 Dimorphic Fungi and Dermatophytes 17.3 Mucorales, Hyaline Molds, Pneumocystis, and Identification Methods
18 Serology
18.1 Immunoglobulin Response and Antigen-Antibody Methods 18.2 Viral Serodiagnosis: Hepatitis, EBV, HIV, CMV, Rubella, Measles 18.3 Treponema, Borrelia, and TB Infection Serodiagnosis
19 Laboratory Operations: Postanalytic Procedures and Quality
19.1 Documentation, Critical Values, Corrected Reports, and Public Health 19.2 Quality Control, Root-Cause Analysis, and POCT 19.3 Proficiency Testing, Competency, and Accreditation
20 Laboratory Operations: Safety, Mathematics, and Instrumentation
20.1 Biosafety, PPE, Bloodborne Pathogens, and SDS 20.2 Emergencies and Packaging/Transportation of Specimens 20.3 Laboratory Mathematics and Instrumentation
10.3 Urinary Pathogens, Colony Counts, and Urinalysis Correlation
Key Takeaways Explain This Topic AI
Urine sources are midstream clean-catch, catheter (port, never a Foley tip), suprapubic aspirate, and nephrostomy; collection quality drives whether mixed growth is contamination.
Major uropathogens include Enterobacterales, Enterococcus spp., S. agalactiae, Candida spp., and Staphylococcus saprophyticus, which is a novobiocin-resistant coagulase-negative staphylococcus.
A 0.001 mL calibrated loop multiplies each colony by 1,000 CFU/mL, so 100 colonies equal 10^5 CFU/mL; a 0.01 mL loop multiplies by 100 CFU/mL.
Classic ≥10^5 CFU/mL remains the ASB cutoff, but symptomatic women, catheter specimens, and any growth from suprapubic urine use lower thresholds.
Correlate culture with leukocyte esterase, nitrite, and WBCs: nitrite-positive results support Enterobacterales, while Enterococcus and S. saprophyticus are nitrite-negative.
Last updated: August 2026
The M(ASCP) urine domain (II.I, guideline revised 2025-09-25) tests specimen sources, identification of major urinary pathogens, correlation of colony counts with clinical significance, and correlation of culture with urinalysis. This is a numbers-and-judgment section: the same 10,000 CFU/mL of Escherichia coli can be contamination, asymptomatic bacteriuria, or a real UTI depending on how the specimen was collected, who the patient is, and whether the dipstick and microscopy agree.
Specimen sources
Midstream clean-catch (MSCC) is the usual outpatient specimen. Instruct the patient to clean the periurethral area, void, then catch the middle of the stream. Even with good technique, periurethral and vaginal flora contaminate many specimens. Interpret mixed diphtheroids, lactobacilli, and coagulase-negative staphylococci from an MSCC as contamination, not as a three-pathogen infection.
Catheterized urine: an in-and-out (straight-catheter) specimen is cleaner than an indwelling Foley. If an indwelling catheter is in place, aspirate from the sampling port after disinfection—never culture the bag, and never culture a Foley catheter tip. Tips grow biofilm and do not represent bladder bacteriuria.
Suprapubic aspiration passes a needle through the abdominal wall into a full bladder. It is the gold-standard collection for infants and selected adults. Because the tract is sterile, any growth can be significant.
Nephrostomy urine comes from a percutaneous tube in the renal pelvis. Treat it as an upper-tract specimen: lower colony counts can still represent true colonization or infection of the kidney, and polymicrobial growth is more plausible than in an MSCC.
Transport within 2 hours at room temperature. If delay is unavoidable, refrigerate or use a boric-acid preservative (gray-top urine culture tube) so colony counts remain stable. Unpreserved urine at room temperature overgrows contaminants and inflates CFU/mL.
Major urinary pathogens: colony morphology and identification
Enterobacterales dominate community UTI. E. coli is a lactose-positive, typically indole-positive Gram-negative rod and causes the large majority of uncomplicated cystitis. Klebsiella spp. are mucoid lactose fermenters. Proteus spp. swarm on blood agar, are urease-positive, alkalinize urine, and are linked to struvite stones. Enterobacter and Citrobacter appear in complicated and healthcare-associated UTI. These organisms are nitrite-positive on dipstick when bladder dwell time is adequate, because they reduce nitrate.
Enterococcus spp. are Gram-positive cocci in pairs and short chains, catalase-negative, PYR-positive, and bile-esculin-positive. They grow in 6.5% NaCl. They do not reduce nitrate, so a nitrite-negative UTI is expected. They are important in catheter-associated and complicated UTI.
Streptococcus agalactiae in urine is both a uropathogen and a GBS-colonization marker in pregnancy. Beta-hemolytic catalase-negative cocci from a pregnant patient's urine should be identified. Laboratories commonly report GBS at ≥10^4 CFU/mL, and GBS bacteriuria during the current pregnancy is an indication for intrapartum prophylaxis. High-count bacteriuria in pregnancy is also treated as a UTI, not only as a colonization flag.
Candida spp. (C. albicans, C. glabrata, others) cause candiduria in catheterized, diabetic, and antibiotic-treated patients. Yeast on the plate should be correlated with yeast on urinalysis. Heavy mixed bacterial contamination plus scant yeast is not automatically a yeast UTI.
Staphylococcus saprophyticus is a coagulase-negative staphylococcus that causes community cystitis in young, sexually active women—a classic exam organism. Colonies are white to slightly yellow and usually nonhemolytic; catalase-positive, coagulase-negative. Novobiocin resistance (5-µg disk) separates it from S. epidermidis, which is novobiocin-susceptible. It is nitrite-negative. Do not discard coagulase-negative staphylococci in urine without a novobiocin result in this demographic.
Pathogen Bench clues Nitrite High-yield context
E. coli and other Enterobacterales GNR; lactose variable; biochemicals or MALDI Usually positive Community and complicated UTI
- Enterococcus spp. GPC, catalase−, PYR+, bile esculin+ Negative Catheter, complicated UTI
- S. agalactiae Beta-hemolytic, CAMP+, hippurate+, PYR− Negative Pregnancy; IAP if bacteriuria
- Candida spp. Budding yeast; chromogenic agar or MALDI Negative Catheter, antibiotics, diabetes
- S. saprophyticus CoNS, novobiocin-resistant Negative Young women, community cystitis
- Colony counts and clinical significance
Kass's classic threshold of ≥10^5 CFU/mL predicted true bacteriuria in asymptomatic women and remains the usual cutoff for asymptomatic bacteriuria (ASB). It is not a universal infection-versus-no-infection line.
Symptomatic women with cystitis can have true infection at 10^2–10^4 CFU/mL of a single uropathogen. Many laboratories still use 10^4 as a default workup threshold for MSCC, but the M exam expects you to lower the threshold when symptoms, pyuria, and a single uropathogen line up. Catheter-associated infection guidelines treat ≥10^3 CFU/mL of a species plus symptoms as significant. Suprapubic and other surgically obtained urine: any growth may be significant. IDSA ASB definitions use ≥10^5 CFU/mL on voided specimens (two consecutive specimens with the same species in women; one in men) and generally recommend not treating ASB except in pregnancy and before selected urologic procedures.
GBS in pregnancy: report at ≥10^4 CFU/mL per CDC laboratory guidance. Clinically, GBS bacteriuria this pregnancy triggers IAP, and high-count bacteriuria is treated as a UTI as well.
Calibrated loop math
Quantitative urine culture uses a calibrated loop, not a streak-for-isolation from an unmeasured drop.
A 0.001 mL (1 µL) loop: each colony = 1,000 CFU/mL. Ten colonies = 10^4 CFU/mL. One hundred colonies = 10^5 CFU/mL. Thirty-five colonies of a single morphology = 3.5 × 10^4 CFU/mL.
A 0.01 mL (10 µL) loop: each colony = 100 CFU/mL. This loop detects the 10^3 range needed for catheters, children, and symptomatic cystitis.
Worked example: a 0.001 mL loop yields 80 colonies of E. coli = 80,000 CFU/mL (8 × 10^4). If the patient is a symptomatic woman with a positive leukocyte esterase and 20 WBC/hpf, this count is significant even though it is just under 10^5. If the same count arrives with three additional skin-flora morphologies and a negative microscopic exam, think contamination.
Second worked example: a 0.01 mL loop yields 25 colonies of S. saprophyticus = 2,500 CFU/mL. In a young woman with dysuria and pyuria, that count can be a real UTI; the same count of mixed diphtheroids from an MSCC is not.
Confluent growth is reported as greater than 10^5 CFU/mL (or the laboratory's equivalent). Do not try to count a lawn and then multiply incorrectly.
Urinalysis correlation
Leukocyte esterase (LE) detects neutrophil esterase and is a proxy for pyuria. Microscopic WBC counts of about ≥5–10/hpf support inflammation. Nitrite detects bacterial reduction of urinary nitrate; it is useful when positive, mainly for Enterobacterales with adequate bladder time. Nitrite is often negative in infection due to Enterococcus, S. saprophyticus, Streptococcus, Acinetobacter, yeast, or a short time since the last void. A negative nitrite never excludes UTI.
Correlate, do not rubber-stamp:
Single uropathogen at a significant count plus LE/WBC: typical UTI.
≥10^5 CFU/mL with no pyuria in an asymptomatic nonpregnant adult: ASB or contamination; do not automatically force susceptibilities into a treatment cascade.
Pyuria with negative culture: prior antibiotics, urethritis (C. trachomatis, N. gonorrhoeae, M. genitalium), tuberculosis, fastidious organisms, or noninfectious inflammation.
Bacteria on an uncentrifuged Gram stain of urine roughly correspond to ≥10^5 CFU/mL.
Mixed flora versus polymicrobial infection
MSCC with three or more morphologies, especially lactobacilli, diphtheroids, and mixed coagulase-negative staphylococci, is contamination—particularly if LE is negative. Recollect rather than identify everything. True polymicrobial UTI occurs with long-term catheters, stones, obstruction, fistula, or ileal conduit: two uropathogens (for example E. coli and Klebsiella pneumoniae) at significant counts with pyuria deserve workup. The exam distinction is mixed skin or vaginal flora from a dirty catch versus a limited number of recognized uropathogens from a catheter or stone patient.
In practice, read the source, do the loop math, look at the UA, then decide whether the plate is a UTI, ASB, contamination, or a true polymicrobial infection. That sequence is the II.I skill the exam is testing.